Effects of Desflurane and Propofol During Lung Volume Reduction Surgery

NCT04226625 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-01-13

No results posted yet for this study

Summary

Patients presenting for lung volume reduction are very high risk patients and it is important they receive the best anesthetic available. This study aims to answer which is the best anesthetic for managing such cases.

Conditions

  • Lung Volume Reduction Surgery

Interventions

DRUG

Propofol

Intravenous administration

DRUG

Desflurane

Volatile administration

Sponsors & Collaborators

Principal Investigators

  • Bessie Kachulis, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2001-03-21
Completion
2002-03-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04226625 on ClinicalTrials.gov